USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| May 17, 2022 (est) | Mar 31, 2022 | - | $-0.28 | $-0.13 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| May 17, 2022 (est) | Mar 31, 2022 | - | $432.04M | $200.32M |
Clover Health Investments's next estimated earnings date (based on same quarter last year's date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 6 | $-0.22 | $-0.29 | $-0.14 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 6 | $-0.93 | $-1.19 | $-0.61 |
| Dec 2023 | 6 | $-0.68 | $-0.90 | $-0.45 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 1 / 0 | $-0.24 | $-0.21 | $-0.18 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 0 | $-1.01 | $-0.90 | $-0.78 |
| Dec 2023 | 2 / 0 | $-0.74 | $-0.65 | $-0.54 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 6 | $807.61M | $758.66M | $829.76M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 7 | $3.23B | $3.03B | $3.33B |
| Dec 2023 | 7 | $4.15B | $3.84B | $4.57B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $-0.26 | $-0.28 | -7.69% |
| Nov 8, 2021 | Sep 2021 | $-0.23 | $-0.08 | 64.94% |
| Aug 11, 2021 | Jun 2021 | $-0.14 | $-0.78 | -472.69% |
| May 17, 2021 | Mar 2021 | $-0.10 | $-0.13 | -34.02% |
| Mar 1, 2021 | Dec 2020 | $-0.46 | $-2.95 | -547.21% |
| Dec 2, 2020 | Sep 2020 | - | $-0.02 | - |
| Sep 30, 2020 | Jun 2020 | - | $0.30 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.27 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.27 | - |
| Sep 30, 2019 | Jun 2019 | - | $-1.21 | - |
| Jun 30, 2019 | Mar 2019 | - | $-2.76 | - |
| Mar 31, 2019 | Dec 2018 | - | $-2.76 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $-1.18 | $-1.27 | - |
| Mar 1, 2021 | Dec 2020 | $0.00 | $-2.94 | - |
| Mar 31, 2020 | Dec 2019 | - | $-4.23 | - |
| Mar 31, 2019 | Dec 2018 | - | $-2.76 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $432.04M | $432.04M | 1.00% |
| Nov 8, 2021 | Sep 2021 | $413.10M | $427.16M | 1.03% |
| Aug 11, 2021 | Jun 2021 | $412.47M | $412.47M | 1.00% |
| May 17, 2021 | Mar 2021 | $200.32M | $200.32M | 1.00% |
| Mar 1, 2021 | Dec 2020 | $166.23M | $-506.65M | - |
| Dec 2, 2020 | Sep 2020 | - | $169.07M | - |
| Sep 30, 2020 | Jun 2020 | - | $172.08M | - |
| Jun 30, 2020 | Mar 2020 | - | $165.50M | - |
| Mar 31, 2020 | Dec 2019 | - | - | - |
| Sep 30, 2019 | Jun 2019 | - | - | - |
| Jun 30, 2019 | Mar 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $1.47B | $1.47B | -0.00% |
| Mar 1, 2021 | Dec 2020 | $672.89M | $672.89M | 0.00% |
| Mar 31, 2020 | Dec 2019 | - | $462.27M | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
CLOV's next estimated earnings date (based on same quarter last year's report date) is May 17, 2022 for the fiscal quarter ending Mar 31, 2022.
Clover Health Investments's previous earnings date was Feb 23, 2022 for its fiscal quarter ended Dec 31, 2021.
CLOV's earnings per share (EPS) was $-0.28, missing the consensus analysts forecast of $-0.26 by -7.69%.
The EPS was lower than the previous fiscal quarter (Sep 2021) by 250.00%, and higher than the same period a year before (Dec 2020) by -90.51%.
Revenues were $432.04M.
The company reported a net income of $-187.20M.Free cash flow for the quarter was $-80.41M , compared to $-45.32M last quarter and $57.00M a year before.
CLOV ended the quarter with $27.83M in total debt, a decrease of -2.28% compared to the previous quarter, and an increase of 3351.59% compared to the same quarter a year before.
Clover Health Investments's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.
CLOV's earnings per share (EPS) was $-1.27, missing the consensus analysts forecast of $-1.18 by 7.63% , and higher than the previous year's EPS (Dec 2020) by -56.82%.
Revenues were $1.47B, worse than the forecast of $1.47B by -0.00%, and up by 118.76% from previous year's revenue.
The company reported a net income of $-587.76M.
Clover Health Investments reported a free cash flow of $-283.05M for its fiscal year, compared to $-2.23M a year ago.
The company ended the fiscal year with $27.83M in total debt, an increase of 3351.59% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
